muscular dystrophy
Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in newborns, infants or children, while others have late-onset and may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance. The prognosis for people with MD varies according to the type and progression of the disorder. There is no specific treatment to stop or reverse any form of MD. Treatment is supportive and may include physical therapy, respiratory therapy, speech therapy, orthopedic appliances used for support, corrective orthopedic surgery, and medicationsincluding corticosteroids, anticonvulsants (seizure medications), immunosuppressants, and antibiotics. Some individuals may need assisted ventilation to treat respiratory muscle weaknessor a pacemaker for cardiac (heart)abnormalities.
MONDO:0100167
pulmonary disease, chronic obstructive, susceptibility to
excluded_subClassOf
MONDO:0005336
myopathy
is_a
MONDO:0100546
hereditary neuromuscular disease
is_a
MONDO:0700223
hereditary skeletal muscle disorder
is_a
SPAC1A6.01c SPAC22A12.07c SPCC1906.01 SPAC23C4.13 SPBC3E7.02c SPAC13G7.12c SPAC31A2.13c SPCC162.09c SPBP23A10.12 SPAC144.03 SPAC30C2.06c SPAC4A8.05c SPAPB1E7.09 SPCC645.05c SPCC63.13 SPBC16E9.12c SPBC16C6.09 SPAC13D6.02c SPBC21B10.11 SPBC26H8.07c SPBC11G11.07 SPBC1677.02 SPCC338.06c SPBC32H8.12c SPCC1235.16